135 related articles for article (PubMed ID: 8201603)
1. Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
Stevens MF; McCall CJ; Lelieveld P; Alexander P; Richter A; Davies DE
J Med Chem; 1994 May; 37(11):1689-95. PubMed ID: 8201603
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity.
Linassier C; Pierre M; Le Pecq JB; Pierre J
Biochem Pharmacol; 1990 Jan; 39(1):187-93. PubMed ID: 2153378
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases.
Cunningham BD; Threadgill MD; Groundwater PW; Dale IL; Hickman JA
Anticancer Drug Des; 1992 Oct; 7(5):365-84. PubMed ID: 1388629
[TBL] [Abstract][Full Text] [Related]
5. Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
Akiyama T; Ogawara H
Methods Enzymol; 1991; 201():362-70. PubMed ID: 1658553
[No Abstract] [Full Text] [Related]
6. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines.
Oude Weernink PA; Verheul E; Kerkhof E; van Veelen CW; Rijksen G
Neurosurgery; 1996 Jan; 38(1):108-13; discussion 113-4. PubMed ID: 8747958
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
Klein JM; McCarthy TA
Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
[TBL] [Abstract][Full Text] [Related]
8. Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity.
Schroeder MC; Hamby JM; Connolly CJ; Grohar PJ; Winters RT; Barvian MR; Moore CW; Boushelle SL; Crean SM; Kraker AJ; Driscoll DL; Vincent PW; Elliott WL; Lu GH; Batley BL; Dahring TK; Major TC; Panek RL; Doherty AM; Showalter HD
J Med Chem; 2001 Jun; 44(12):1915-26. PubMed ID: 11384237
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
10. Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzothiazoles.
Vasselin DA; Westwell AD; Matthews CS; Bradshaw TD; Stevens MF
J Med Chem; 2006 Jun; 49(13):3973-81. PubMed ID: 16789754
[TBL] [Abstract][Full Text] [Related]
11. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
[TBL] [Abstract][Full Text] [Related]
12. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene.
Peterson G; Barnes S
Biochem Biophys Res Commun; 1991 Aug; 179(1):661-7. PubMed ID: 1883387
[TBL] [Abstract][Full Text] [Related]
13. Antitumour benzothiazoles. Part 10: the synthesis and antitumour activity of benzothiazole substituted quinol derivatives.
Wells G; Bradshaw TD; Diana P; Seaton A; Shi DF; Westwell AD; Stevens MF
Bioorg Med Chem Lett; 2000 Mar; 10(5):513-5. PubMed ID: 10743960
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells.
Balbaa M; Honke K; Makita A
Biochim Biophys Acta; 1996 Jan; 1299(1):141-5. PubMed ID: 8555246
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases.
Thompson AM; Fry DW; Kraker AJ; Denny WA
J Med Chem; 1994 Mar; 37(5):598-609. PubMed ID: 7510340
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors.
Geissler JF; Traxler P; Regenass U; Murray BJ; Roesel JL; Meyer T; McGlynn E; Storni A; Lydon NB
J Biol Chem; 1990 Dec; 265(36):22255-61. PubMed ID: 2176210
[TBL] [Abstract][Full Text] [Related]
17. The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase.
El-Zarruk AA; van den Berg HW
Cancer Lett; 1999 Aug; 142(2):185-93. PubMed ID: 10463775
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases.
Palmer BD; Rewcastle GW; Thompson AM; Boyd M; Showalter HD; Sercel AD; Fry DW; Kraker AJ; Denny WA
J Med Chem; 1995 Jan; 38(1):58-67. PubMed ID: 7837241
[TBL] [Abstract][Full Text] [Related]
19. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]